[HTML][HTML] Mechanisms of resistance to immune checkpoint inhibitors
Immune checkpoint inhibitors (ICI) targeting CTLA-4 and the PD-1/PD-L1 axis have shown
unprecedented clinical activity in several types of cancer and are rapidly transforming the …
unprecedented clinical activity in several types of cancer and are rapidly transforming the …
[HTML][HTML] Mechanisms of resistance to immune checkpoint inhibitors
RW Jenkins, DA Barbie, KT Flaherty - British Journal of Cancer, 2018 - ncbi.nlm.nih.gov
Immune checkpoint inhibitors (ICI) targeting CTLA-4 and the PD-1/PD-L1 axis have shown
unprecedented clinical activity in several types of cancer and are rapidly transforming the …
unprecedented clinical activity in several types of cancer and are rapidly transforming the …
Mechanisms of resistance to immune checkpoint inhibitors
RW Jenkins, DA Barbie… - British journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
Immune checkpoint inhibitors (ICI) targeting CTLA-4 and the PD-1/PD-L1 axis have shown
unprecedented clinical activity in several types of cancer and are rapidly transforming the …
unprecedented clinical activity in several types of cancer and are rapidly transforming the …
[引用][C] Mechanisms of resistance to immune checkpoint inhibitors
RW Jenkins, DA Barbie, KT Flaherty - British Journal of Cancer, 2018 - cir.nii.ac.jp
Mechanisms of resistance to immune checkpoint inhibitors
RW Jenkins, DA Barbie, KT Flaherty - British Journal of Cancer, 2018 - dash.harvard.edu
Immune checkpoint inhibitors (ICI) targeting CTLA-4 and the PD-1/PD-L1 axis have shown
unprecedented clinical activity in several types of cancer and are rapidly transforming the …
unprecedented clinical activity in several types of cancer and are rapidly transforming the …
Mechanisms of resistance to immune checkpoint inhibitors.
RW Jenkins, DA Barbie, KT Flaherty - British Journal of Cancer, 2018 - europepmc.org
Immune checkpoint inhibitors (ICI) targeting CTLA-4 and the PD-1/PD-L1 axis have shown
unprecedented clinical activity in several types of cancer and are rapidly transforming the …
unprecedented clinical activity in several types of cancer and are rapidly transforming the …
Mechanisms of resistance to immune checkpoint inhibitors.
RW Jenkins, DA Barbie, KT Flaherty - British Journal of Cancer, 2018 - europepmc.org
Immune checkpoint inhibitors (ICI) targeting CTLA-4 and the PD-1/PD-L1 axis have shown
unprecedented clinical activity in several types of cancer and are rapidly transforming the …
unprecedented clinical activity in several types of cancer and are rapidly transforming the …